These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26666938)

  • 21. Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era?
    Pascual Á; Pintado V; Rodríguez-Baño J; Miró JM
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():1-3. PubMed ID: 25542045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
    Asai N; Sakanashi D; Suematsu H; Kato H; Hagihara M; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
    J Infect Chemother; 2018 Jul; 24(7):505-509. PubMed ID: 29548627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial treatment and outcomes of critically ill patients with OXA-48like carbapenemase-producing Enterobacteriaceae infections.
    Lowman W; Schleicher G
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):138-40. PubMed ID: 25497419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intense intestinal carriage and subsequent acquisition of multidrug-resistant enterobacteria in neonatal intensive care unit in Morocco.
    Arhoune B; El Fakir S; Himri S; Moutaouakkil K; El Hassouni S; Benboubker M; Hmami F; Oumokhtar B
    PLoS One; 2021; 16(6):e0251810. PubMed ID: 34191805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active case finding for carbapenemase-producing Enterobacteriaceae in a teaching hospital: prevalence and risk factors for colonization.
    Poole K; George R; Decraene V; Shankar K; Cawthorne J; Savage N; Welfare W; Dodgson A
    J Hosp Infect; 2016 Oct; 94(2):125-9. PubMed ID: 27542962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of Enterobacteriaceae infections stratified by carbapenem MICs.
    Patel TS; Nagel JL
    J Clin Microbiol; 2015 Jan; 53(1):201-5. PubMed ID: 25378572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos.
    Savard P; Carroll KC; Wilson LE; Perl TM
    Infect Control Hosp Epidemiol; 2013 Jul; 34(7):730-9. PubMed ID: 23739078
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk factors for fecal carriage of IMP-6-producing Enterobacteriaceae at a long-term care hospital in Japan: A follow-up report from the northern Osaka multicentre study group.
    Hagiya H; Yamamoto N; Kawahara R; Akeda Y; Shanmugakani RK; Ueda A; Nishi I; Asada R; Yoshida H; Tomono K
    J Infect Chemother; 2018 Sep; 24(9):769-772. PubMed ID: 29656900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
    Stock I
    Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotics with activity against intestinal anaerobes and the hazard of acquired colonization with ceftriaxone-resistant Gram-negative pathogens in ICU patients: a propensity score-based analysis.
    Boutrot M; Azougagh K; Guinard J; Boulain T; Barbier F
    J Antimicrob Chemother; 2019 Oct; 74(10):3095-3103. PubMed ID: 31289826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbapenemase-producing enterobacteriaceae (CPE) in the pediatric setting: results from an 18-month survey.
    Colombo S; Scolfaro C; Calitri C; Denina M; Carraro F; De Intinis G; Tovo PA
    Infect Control Hosp Epidemiol; 2014 May; 35(5):599-601. PubMed ID: 24709738
    [No Abstract]   [Full Text] [Related]  

  • 32. The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study.
    Dautzenberg MJ; Wekesa AN; Gniadkowski M; Antoniadou A; Giamarellou H; Petrikkos GL; Skiada A; Brun-Buisson C; Bonten MJ; Derde LP;
    Crit Care Med; 2015 Jun; 43(6):1170-7. PubMed ID: 25882764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors and clinical features of infections caused by plasmid-mediated AmpC beta-lactamase-producing Enterobacteriaceae.
    Park YS; Yoo S; Seo MR; Kim JY; Cho YK; Pai H
    Int J Antimicrob Agents; 2009 Jul; 34(1):38-43. PubMed ID: 19297134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outbreak of carbapenem-resistant Providencia stuartii in an intensive care unit.
    Zavascki AP; Carvalhaes CG; da Silva GL; Tavares Soares SP; de Alcântara LR; Elias LS; Sandri AM; Gales AC
    Infect Control Hosp Epidemiol; 2012 Jun; 33(6):627-30. PubMed ID: 22561721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.
    Moland ES; Hanson ND; Black JA; Hossain A; Song W; Thomson KS
    J Clin Microbiol; 2006 Sep; 44(9):3318-24. PubMed ID: 16954267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bahrain.
    Bindayna KM; Senok AC; Jamsheer AE
    J Infect Public Health; 2009; 2(3):129-35. PubMed ID: 20701872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings.
    Bou G; Vila J; Seral C; Castillo FJ
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():24-32. PubMed ID: 25542049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Future alternatives for the treatment of infections caused by carbapenemase-producing Enterobacteriaceae: what is in the pipeline?
    Horcajada JP; Torre-Cisneros J; Peña C; Fariñas MC
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():56-60. PubMed ID: 25542053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enterobacteriaceae bacteremia: risk factors for ESBLPE.
    Neulier C; Birgand G; Ruppé É; Armand-Lefèvre L; Lolom I; Yazdanpanah Y; Lucet JC; Andremont A
    Med Mal Infect; 2014 Jan; 44(1):32-8. PubMed ID: 24321202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
    Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
    Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.